We are live on ! Find out more
INBX

Inhibrx, Inc. Common Stock
INBX

Delisted

INBX was delisted on the 29th of May, 2024.

Back to rankings

102 hedge funds and large institutions have $512M invested in Inhibrx, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 46 increasing their positions, 27 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more capital invested

Capital invested by funds: $297M → $512M (+$215M)

70% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 27

17% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 12

2% more funds holding

Funds holding: 100 → 102 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

97% less call options, than puts

Call options by funds: $369K | Put options by funds: $12.7M

Holders
102
Holders Change
+2
Holders Change %
+2%
% of All Funds
1.76%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
46
Reduced
27
Closed
12
Calls
$369K
Puts
$12.7M
Net Calls
-$12.3M
Net Calls Change
-$12.5M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$27.2M
2
PA
Perceptive Advisors
New York
+$17.5M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$10.6M
4
SCM
Soleus Capital Management
Connecticut
+$6.56M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$5.68M

Top Sellers

Rank Fund Capital Flow
1
Capital World Investors
Capital World Investors
California
-$18.5M
2
Millennium Management
Millennium Management
New York
-$8.12M
3
OM
Opaleye Management
Massachusetts
-$5.36M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$4.36M
5
SCM
Sio Capital Management
New York
-$4.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Advisers
26
Two Sigma Advisers
New York
$2.69M +$1.9M +105,600 +239%
PIM
27
Platinum Investment Management
Australia
$2.62M -$250K -13,889 -9%
LNWWM
28
Laird Norton Wetherby Wealth Management
California
$2.46M – – –
Rafferty Asset Management
29
Rafferty Asset Management
New York
$2.39M +$2.4M +132,999 New
HighTower Advisors
30
HighTower Advisors
Illinois
$2.37M +$2.2M +121,900 +1,219%
Bank of America
31
Bank of America
North Carolina
$2.3M +$2.1M +116,255 +999%
MWA
32
Meridian Wealth Advisors
Texas
$2.2M – – –
Citigroup
33
Citigroup
New York
$2.18M +$2.13M +118,361 +3,818%
N
34
Nuveen
North Carolina
$2.06M -$8.85K -491 -0.4%
Walleye Capital
35
Walleye Capital
New York
$1.97M +$751K +41,678 +61%
WP
36
Woodline Partners
California
$1.85M +$1.86M +103,097 New
Bank of New York Mellon
37
Bank of New York Mellon
New York
$1.74M +$256K +14,202 +17%
Barclays
38
Barclays
United Kingdom
$1.52M +$1.51M +83,981 +2,712%
Victory Capital Management
39
Victory Capital Management
Texas
$1.38M -$220K -12,200 -14%
CSS
40
Cubist Systematic Strategies
Connecticut
$1.38M +$296K +16,429 +27%
UOC
41
UBS O'Connor
Illinois
$1.28M -$248K -13,753 -16%
BC
42
Birchview Capital
Vermont
$1.26M – – –
D.E. Shaw & Co
43
D.E. Shaw & Co
New York
$1.25M -$925K -51,293 -42%
Los Angeles Capital Management
44
Los Angeles Capital Management
California
$1.09M +$1.1M +61,030 New
Swiss National Bank
45
Swiss National Bank
Switzerland
$996K +$34.3K +1,900 +4%
Citadel Advisors
46
Citadel Advisors
Florida
$969K +$171K +9,482 +21%
Adage Capital Partners
47
Adage Capital Partners
Massachusetts
$898K +$901K +50,000 New
BNP Paribas Financial Markets
48
BNP Paribas Financial Markets
France
$885K +$889K +49,318 New
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
$807K +$249K +13,810 +44%
BG
50
Bellevue Group
Switzerland
$781K -$597K -33,100 -43%
1
2
3 4 5

INBX Hedge Fund Activity: Q3 2022 in Review

102 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Inhibrx, Inc. Common Stock (INBX) for Q3 2022, worth a combined $512M — up 72% from $297M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new INBX positions and 12 closed out — a net gain of 2 holders — while 46 added to existing stakes and 27 trimmed.

The largest buyer was State Street, adding an estimated $27.2M. The largest seller was Capital World Investors, exiting entirely with an estimated $18.5M sold.

  • 102 institutional investors held Inhibrx, Inc. Common Stock (INBX) as of Q3 2022, up from 100 in Q2 2022.
  • Funds reported $512M of Inhibrx, Inc. Common Stock stock for Q3 2022, up 72% quarter-over-quarter.
  • 14 funds opened new Inhibrx, Inc. Common Stock positions in Q3 2022 and 12 closed out, a net change of +2 holders.
  • The largest Inhibrx, Inc. Common Stock buyer in Q3 2022 was State Street, an estimated $27.2M added.
  • The largest Inhibrx, Inc. Common Stock seller in Q3 2022 was Capital World Investors, an estimated $18.5M sold.

Based on aggregated 13F filings for Q3 2022.